Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Sublingual tizanidine 12 mg | [1] Tizanidine Tizanidine | [2] D00776
D00776
(Name: Tizanidine hydrochloride),D08611 (Name: Tizanidine) | [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
| 2 | Tizanidine | [1] Tizanidine Tizanidine | [2] D00776
D00776
(Name: Tizanidine hydrochloride),D08611 (Name: Tizanidine) | [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
| 3 | Tizanidine (sublingual or oral) | [1] Tizanidine Tizanidine | [2] D00776
D00776
(Name: Tizanidine hydrochloride),D08611 (Name: Tizanidine) | [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
| 4 | Tizanidine hydrochloride capsule | [1] Tizanidine Tizanidine | [2] D00776
D00776
(Name: Tizanidine hydrochloride),D08611 (Name: Tizanidine) | [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 |